Interchangeable SF3B1 inhibitors interfere with pre-mRNA splicing at multiple stages

(Downloading may take up to 30 seconds. If the slide opens in your browser, select File -> Save As to save it.)

Click on image to view larger version.

FIGURE 5.
FIGURE 5.

Bimolecular assay shows that PB inhibits exon ligation. (A) Schematic of the bimolecular exon ligation reaction. The 5′ substrate consists of a 5′ exon and intron containing the branch point and PYT and is capable of 1st step splicing chemistry to produce splicing intermediates. The 3′ substrate consists of a 3′ splice site and 3′ exon and is capable of 2nd step chemistry to produce mRNA when added in trans. To test for inhibition, PB is added with the 3′ substrate. (B) Denaturing gel analysis of in vitro bimolecular exon ligation reactions. Identities of bands are schematized to the left as (from top to bottom) lariat intermediate, 5′ substrate, mRNA, 5′ exon, and 3′ exon. A 3-d exposure is shown for the top region of the gel, while the bottom region is a 1-d exposure. In lanes 1 and 2, both 5′ and 3′ substrates are radiolabeled. In lanes 317, only the 3′ substrate is radiolabeled. In lanes 49, increasing concentrations of PB (2) (0.1, 1, 2, 5, 10, 100 µM) were included with the 3′ substrate. In lanes 1012 and 1416, active compound was added at 2 µM and increasing concentrations of inactive compounds were added at the indicated ratio. In lanes 13 and 17, inactive compound is at 200 µM.

This Article

  1. RNA 22: 350-359